301 related articles for article (PubMed ID: 23880164)
1. Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Zhang X; He C; He C; Chen B; Liu Y; Kong M; Wang C; Lin L; Dong Y; Sheng H
Pathol Res Pract; 2013 Aug; 209(8):510-5. PubMed ID: 23880164
[TBL] [Abstract][Full Text] [Related]
2. Expression patterns of three regulation enzymes in glycolysis in esophageal squamous cell carcinoma: association with survival.
Li W; Xu Z; Hong J; Xu Y
Med Oncol; 2014 Sep; 31(9):118. PubMed ID: 25064730
[TBL] [Abstract][Full Text] [Related]
3. High expression of PKM2 as a poor prognosis indicator is associated with radiation resistance in cervical cancer.
Zhao Y; Shen L; Chen X; Qian Y; Zhou Q; Wang Y; Li K; Liu M; Zhang S; Huang X
Histol Histopathol; 2015 Nov; 30(11):1313-20. PubMed ID: 25936600
[TBL] [Abstract][Full Text] [Related]
4. Pyruvate kinase M2 is highly correlated with the differentiation and the prognosis of esophageal squamous cell cancer.
Zhan C; Shi Y; Lu C; Wang Q
Dis Esophagus; 2013; 26(7):746-53. PubMed ID: 23317289
[TBL] [Abstract][Full Text] [Related]
5. Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis.
Hasan R; Sharma R; Saraya A; Chattopadhyay TK; DattaGupta S; Walfish PG; Chauhan SS; Ralhan R
BMC Cancer; 2014 Jan; 14():2. PubMed ID: 24383423
[TBL] [Abstract][Full Text] [Related]
6. Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.
Yao W; Qin X; Qi B; Lu J; Guo L; Liu F; Liu S; Zhao B
Int J Clin Exp Pathol; 2014; 7(10):7158-63. PubMed ID: 25400812
[TBL] [Abstract][Full Text] [Related]
7. M2 isoform of pyruvate kinase (PKM2) is upregulated in Kazakh's ESCC and promotes proliferation and migration of ESCC cells.
Liu Q; Liang M; Liu T; Vuitton L; Zheng S; Gao X; Lu M; Li X; Sheyhidin I; Lu X
Tumour Biol; 2016 Feb; 37(2):2665-72. PubMed ID: 26404132
[TBL] [Abstract][Full Text] [Related]
8. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
[TBL] [Abstract][Full Text] [Related]
9. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.
Sun N; Ye L; Chang T; Li X; Li X
Int J Clin Exp Pathol; 2014; 7(10):6871-9. PubMed ID: 25400770
[TBL] [Abstract][Full Text] [Related]
10. High level of microtubule-associated protein light chain 3 predicts poor prognosis in resectable esophageal squamous cell carcinoma.
Hao CL; Li Y; Yang HX; Luo RZ; Zhang Y; Zhang MF; Cheng YF; Wang X
Int J Clin Exp Pathol; 2014; 7(7):4213-21. PubMed ID: 25120801
[TBL] [Abstract][Full Text] [Related]
11. ADAMTS-6 is a predictor of poor prognosis in patients with esophageal squamous cell carcinoma.
Liu L; Yang Z; Ni W; Xuan Y
Exp Mol Pathol; 2018 Apr; 104(2):134-139. PubMed ID: 29475036
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
13. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
[TBL] [Abstract][Full Text] [Related]
14. TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Pham QT; Oue N; Sekino Y; Yamamoto Y; Shigematsu Y; Sakamoto N; Sentani K; Uraoka N; Yasui W
Oncology; 2018; 95(5):297-308. PubMed ID: 30134247
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of GRB2 is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Li LY; Li EM; Wu ZY; Cao HH; Shen JH; Xu XE; Chen B; Wu JY; Xu LY
Int J Clin Exp Pathol; 2014; 7(6):3132-40. PubMed ID: 25031732
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma.
Chen K; Cheng G; Zhang F; Zhang N; Li D; Jin J; Wu J; Ying L; Mao W; Su D
Oncotarget; 2016 May; 7(21):30772-80. PubMed ID: 27120796
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance and function of the vacuolar H+-ATPase subunit V1E1 in esophageal squamous cell carcinoma.
Son SW; Kim SH; Moon EY; Kim DH; Pyo S; Um SH
Oncotarget; 2016 Aug; 7(31):49334-49348. PubMed ID: 27384996
[TBL] [Abstract][Full Text] [Related]
18. Alterations in glucose metabolism proteins responsible for the Warburg effect in esophageal squamous cell carcinoma.
de Andrade Barreto E; de Souza Santos PT; Bergmann A; de Oliveira IM; Wernersbach Pinto L; Blanco T; Rossini A; Pinto Kruel CD; Mattos Albano R; Ribeiro Pinto LF
Exp Mol Pathol; 2016 Aug; 101(1):66-73. PubMed ID: 27260309
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.
Deng F; Zhou K; Cui W; Liu D; Ma Y
Int J Clin Exp Pathol; 2015; 8(3):3045-53. PubMed ID: 26045816
[TBL] [Abstract][Full Text] [Related]
20. Loss of PAR-3 protein expression is associated with invasion, lymph node metastasis, and poor survival in esophageal squamous cell carcinoma.
Kitaichi T; Yasui K; Gen Y; Dohi O; Iwai N; Tomie A; Yamada N; Terasaki K; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Sumida Y; Mitsuyoshi H; Naito Y; Zen Y; Itoh Y
Hum Pathol; 2017 Apr; 62():134-140. PubMed ID: 28188749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
